Cited by 253Venous Thromboembolism Diagnosis and ManagementReproductive Health and ContraceptionBlood Coagulation and Thrombosis Mechanisms

A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception

Open access
Dragoman, Monica V., Tepper, Naomi K., Fu, Rongwei, Curtis, Kathryn M., Chou, Roger, Gaffield, Mary E.·2018·International Journal of Gynecology & Obstetrics

Abstract

BACKGROUND: Combined oral contraceptives (COCs) containing various progestogens could be associated with differential risks for venous thromboembolism (VTE). OBJECTIVE: To evaluate the comparative risks of VTE associated with the use of low-dose (less than 50 μg ethinyl estradiol) COCs containing different progestogens. SEARCH STRATEGY: PubMed and the Cochrane Library were searched from database inception through September 15, 2016, by combining search terms for oral contraception and venous thrombosis. SELECTION CRITERIA: Studies reporting VTE risk estimates among healthy users of progestogen-containing low-dose COCs were included. DATA COLLECTION AND ANALYSIS: A random-effects model was used to generate pooled adjusted risk ratios and 95% confidence intervals; subgroup and sensitivity analyses assessed the impact of monophasic-COC use and study-level characteristics. MAIN RESULTS: There were 22 articles included in the analysis. The use of COCs containing cyproterone acetate, desogestrel, drospirenone, or gestodene was associated with a significantly increased risk of VTE compared with the use of levonorgestrel-containing COCs (pooled risk ratios 1.5-2.0). The analysis restricted to monophasic COC formulations with 30 μg of ethinyl estradiol yielded similar findings. After adjustment for study characteristics, the risk estimates were slightly attenuated. CONCLUSIONS: Compared with the use of levonorgestrel-containing COCs, the use of COCs containing other progestogens could be associated with a small increase in risk for VTE.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijgo.12455

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the general population, CPA increases the risk of venous thromboembolism compared with other COCP.

    “General population studies have shown that CPA increases the risk of venous thromboembolism compared with other COCP (71, 72); hence, COCPs containing CPA are currently not recommended as first-line treatments for PCOS (20).”

    From Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis (2024) · cites this paper as [71]

    The Results report that cyproterone acetate (CPA)-containing combined oral contraceptives were associated with increased VTE risk compared with levonorgestrel-containing contraceptives. The claim broadens that specific comparator to “other COCP” generally and states the association as a causal increase. Page numbers are unavailable in our copy. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dragoman, M. V., Tepper, N. K., Fu, R., Curtis, K. M., Chou, R., & Gaffield, M. E.
Affiliations
  • World Health Organization (CH)
  • Centers for Disease Control and Prevention (US)
  • Oregon Health & Science University (US)
Corresponding author
Tepper, Naomi K.
Venue
International Journal of Gynecology & Obstetrics
Publisher
Wiley
Published
2018-02-22
Volume
141
Issue
3
Pages
287-294
ISSN
  • 0020-6695 (ISSN-L)
  • 0020-7292
  • 1879-3479
OpenAlex
W2790432733
Cited by
253
References
53
Citations by year
2026: 18 · 2025: 26 · 2024: 34 · 2023: 45 · 2022: 30 · 2021: 39 · 2020: 32 · 2019: 18 · 2018: 10
FWCI
6.80
Type
journal article
Language
en
Open access
Locations
  • International Journal of Gynecology & Obstetrics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • World Health Organization
  • National Institute of Child Health and Human Development
  • United States Agency for International Development
Topics
  • Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords
venous thromboembolism, combined oral contraceptives, progestogens, levonorgestrel, cyproterone acetate, desogestrel, drospirenone, gestodene, monophasic oral contraceptives, thrombosis risk
MeSH terms
Contraceptives, Oral, Combined, Ethinyl Estradiol, Female, Humans, Progestins, Risk, Odds Ratio, Venous Thrombosis, Venous Thromboembolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review